CLINICAL RESEARCH
Diseases don’t cause dysfunction; dysfunction causes disease. Decades of clinical research have taught Dr. Goodenowe that diseases are an opportunity to learn more about optimal health.
- Restore function. Cure disease.
- Maintain function. Prevent disease.
- Optimize function. Achieve vitality.
Laboratory
Dr. Goodenowe wants to know everything he can about diseases and how deviations from health lead to disease, and how to restore these deviations back to normal.
His laboratory is his playground; this is what he does for fun. Dr. Goodenowe’s lab has five different mass spectrometers in addition to other lab equipment that he uses to analyze blood samples to collect massive amounts of data. His curiosity about the biochemical foundations of life led him to invent numerous laboratory methods – the tools he needed to answer his questions simply did not exist, so he had to invent them.
Today, his lab is capable of measuring thousands of molecules in biological samples, not only using his patented system invented in 1999 that still remains the most advanced of its kind, but also using numerous other systems custom designed and developed by Dr. Goodenowe.
Not only did he have to invent the laboratory systems and reagents necessary to measure what he wanted to know, but he had to invent software and data processing systems to help make sense of the complex data gathered from each sample.
Samples Dr. Goodenowe has analyzed include:
- Blood, serum, plasma
- Cerebral spinal fluid
- Tissues including brain, liver, spleen, lung
Clinical Research Projects
Dr. Goodenowe has numerous clinical research projects completed, ongoing, and planned. The projects include collaborations with researchers from around the world, clinical trials with the network of doctors that are part of the ProdromeScan Certification Course, and community trials to deliver health solutions to those who may benefit most.
Research projects are planned or ongoing in the following areas; contact us for more information including questions about enrolment.
- Developmental Diseases of Children (Inborn)
- Peroxisomal (RCDP, Refsum, Zellweger)
- Lysosomal
- Developmental Diseases of Children (Acquired)
- Autism
- PANDAS
- Premature birth
- Neurological Diseases of Midlife
- Multiple sclerosis
- ALS
- Concussion
- Bipolar disorder
- Schizophrenia
- Neurological Diseases of Later Life
- Parkinson's
- Alzheimer's and related dementias
- Sarcopenia
- Cancer
- Colon
- Pancreatic
- Ovarian
- Breast
- Pulmonary Diseases
- Asthma
- Bronchial dysplasia
- COVID
- Cardiovascular and Cerebrovascular
clinical research projects
Dr. Goodenowe has numerous clinical research projects completed, ongoing, and planned. The projects include collaborations with international researchers world wide, clinical trials with the network of doctors that are part of the ProdromeScan Certification Course, and community trials to deliver health solutions to those who may benefit most.
- Peroxisomal Diseases of Children
- Autism and PANDAS_Keller
- Parkinson’s and ALS
- Dementia_Jordan1
- Dementia_Kuryama
- Dementia_Rush
- Dementia_Jordan2
- Colon Cancer_Chiba
- Pancreatic Cancer_Chiba
- Breast Cancer_Kyoto
- Neurological disease_NCNP
- Bronchial Dysplasia
- Asthma
- Sarcopenia
Featured Projects:
THE PROMISE
The promise of Dr. Goodenowe’s research is exemplified by his plasmalogen supplements. It is through his research collaborations and advanced laboratory systems that he was able to discover plasmalogens and their deficiency in Alzheimer’s disease. Through his research he also explored the role of plasmalogens in other diseases including Parkinson’s disease, multiple sclerosis, and cancer.
Now that Dr. Goodenowe has commercialized naturally occurring plasmalogen precursor supplements, this is just the beginning. He will continue to evaluate the role of plasmalogens in conjunction with other supportive biochemical and lifestyle therapies.
And most importantly, he will make sure that everyone who needs plasmalogens will be able to access them. This will take time. But it will happen. He is starting with the most urgent of those cases – children born with peroxisomal diseases.
